MicroRNA-429 modulates hepatocellular carcinoma prognosis and tumorigenesis

Gastroenterology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Huang, Xiao Ying ^a   Yao, Jin Guang ^a   Huang, Hong Dong ^b   Wang, Chao ^a   Ma, Yun ^c   Xia, Qiang ^d   Long, Xi Dai ^a,d  

^a YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; MICRORNA; MICRORNA 429; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DNA ADDUCT; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RECURRENCE FREE SURVIVAL; TUMOR VOLUME; UPREGULATION;

EID: 84885436969     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2013/804128     Document Type: Article

References (45)

1. Xia Q., Huang X. Y., Xue F., Chen C., Genetic polymorphisms of DNA repair genes and DNA repair capacity related to aflatoxin b1 (AFB1)-induced DNA damages. New Research Directions in DNA Repair 2013 1st Rijeka, Croatia InTech 377 412
2. Long X. D., Yao J. G., Zeng Z., Kruman I., DNA repair capacity-related to genetic polymorphisms of DNA repair genes and aflatoxin B1-related hepatocellular carcinoma among Chinese population. DNA Repair 2011 Rijeka, Croatia InTech 505 524
3. Parkin D. M., Bray F., Ferlay J., Pisani P., Global cancer statistics, 2002. A Cancer Journal for Clinicians 2005 55 2 74 108 2-s2.0-14944385553 (Pubitemid 40372904)
4. Zhu A. X., Duda D. G., Sahani D. V., Jain R. K., HCC and angiogenesis: possible targets and future directions. Nature Reviews Clinical Oncology 2011 8 5 292 301 2-s2.0-79955580873 10.1038/nrclinonc.2011.30
5. Kim J. Y., Chung S. M., Choi B. O., Kay C. S., Hepatocellular carcinoma with portal vein tumor thrombosis: improved treatment outcomes with external beam radiation therapy. Hepatology Research 2011 41 9 813 824 2-s2.0-80052230611 10.1111/j.1872-034X.2011.00826.x
6. Ma A. M., Luo Y. X., Wan J. L., Long X. D., Huang Y. Z., An investigative analysis of incidence, prevention, and treatment of hepatocellular carcinoma in Xiangzhou, Baise, Guangxi Autonomous Region, China. Youjiang Minzu Yixueyuan Bao 2010 32 2 165 166
7. Mínguez B., Tovar V., Chiang D., Villanueva A., Llovet J. M., Pathogenesis of hepatocellular carcinoma and molecular therapies. Current Opinion in Gastroenterology 2009 25 3 186 194 2-s2.0-67651107338 10.1097/MOG.0b013e32832962a1
8. Xia H., Ooi L. L., Hui K. M., MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology 2013 58 2 629 641
9. Lin L., Lin Y., Jin Y., Zheng C., Microarray analysis of microRNA expression in liver cancer tissues and normal control. Gene 2013 523 2 158 160
10. Jin X. L., Sun Q. S., Liu F., microRNA 21-mediated suppression of Sprouty1 by Pokemon affects liver cancer cell growth and proliferation. Journal of Cellular Biochemistry 2013 114 7 1625 1633
11. Kumar A., MicroRNA in HCV infection and liver cancer. Biochimica et Biophysica Acta 2011 1809 11-12 694 699 2-s2.0-80655149035 10.1016/j.bbagrm. 2011.07.010
12. Zhang G., Wang Q., Xu R., Therapeutics based on microRNA: a new approach for liver cancer. Current Genomics 2010 11 5 311 325 2-s2.0-77956553611 10.2174/138920210791616671
13. Sun T., Wang C., Xing J., Wu D., miR-429 Modulates the expression of c-myc in human gastric carcinoma cells. European Journal of Cancer 2011 47 17 2552 2559 2-s2.0-80755189933 10.1016/j.ejca.2011.05.021
14. Bracken C. P., Gregory P. A., Kolesnikoff N., Bert A. G., Wang J., Shannon M. F., Goodall G. J., A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Research 2008 68 19 7846 7854 2-s2.0-54049084380 10.1158/0008-5472.CAN-08-1942
15. Li J., Du L., Yang Y., MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Letters 2013 329 1 84 90
16. Hashimoto Y., Akiyama Y., Yuasa Y., Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer. PLoS One 2013 8 5 e62589
17. Liu D., Xia P., Diao D., MiRNA-429 suppresses the growth of gastric cancer cells in vitro. Journal of Biomedical Research 2012 26 5 389 393 10.7555/JBR.26.20120029
18. Chen J., Wang L., Matyunina L. V., Hill C. G., McDonald J. F., Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. Gynecologic Oncology 2011 121 1 200 205 2-s2.0-79952815913 10.1016/j.ygyno.2010.12.339
19. Long X. D., Yao J. G., Zeng Z., Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma. Hepatology 2013 58 1 171 181
20. Long X. D., Zhao D., Wang C., Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma. Epidemiology 2013 24 5 671 681
21. CSLC, CSCO, Diagnosis and treatment of primary liver cancer: a standardized expert consensus. Chinese Clinical Oncology 2009 14 3 259 269
22. Long X. D., Ma Y., Zhou Y. F., Ma A., Fu G., Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population. Hepatology 2010 52 4 1301 1309 2-s2.0-77957946649 10.1002/hep.23807
23. Long X. D., Ma Y., Zhou Y. F., Yao J. G., Ban F. Z., Huang Y. Z., Huang B. C., XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk. BMC Cancer 2009 9 400 2-s2.0-71049137345 10.1186/1471-2407-9-400
24. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
25. Tandon P., Garcia-Tsao G., Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver International 2009 29 4 502 510 2-s2.0-62749123476 10.1111/j.1478-3231.2008.01957.x
26. Landi D., Gemignani F., Barale R., Landi S., A catalog of polymorphisms falling in microRNA-binding regions of cancer genes. DNA and Cell Biology 2008 27 1 35 43 2-s2.0-38349186330 10.1089/dna.2007.0650
27. Lynam-Lennon N., Maher S. G., Reynolds J. V., The roles of microRNA in cancer and apoptosis. Biological Reviews 2009 84 1 55 71 2-s2.0-58849139162 10.1111/j.1469-185X.2008.00061.x
28. Pillai R. S., Bhattacharyya S. N., Filipowicz W., Repression of protein synthesis by miRNAs: how many mechanisms? Trends in Cell Biology 2007 17 3 118 126 2-s2.0-33846277696 10.1016/j.tcb.2006.12.007 (Pubitemid 46357525)
29. Sevignani C., Calin G. A., Siracusa L. D., Croce C. M., Mammalian microRNAs: a small world for fine-tuning gene expression. Mammalian Genome 2006 17 3 189 202 2-s2.0-33644659734 10.1007/s00335-005-0066-3 (Pubitemid 43327650)
30. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5 (Pubitemid 38167318)
31. Esteller M., Non-coding RNAs in human disease. Nature Reviews Genetics 2011 12 12 861 874 2-s2.0-81355142141 10.1038/nrg3074
32. van Rooij E., The art of MicroRNA research. Circulation Research 2011 108 2 219 234 2-s2.0-79251581020 10.1161/CIRCRESAHA.110.227496
33. Vera J., Lai X., Schmitz U., Wolkenhauer O., MicroRNA-regulated networks: the perfect storm for classical molecular biology, the ideal scenario for systems biology. Advances in Experimental Medicine and Biology 2013 774 55 76 10.1007/978-94-007-5590-1-4
34. Aguda B. D., Modeling microRNA-transcription factor networks in cancer. Advances in Experimental Medicine and Biology 2013 774 149 167 10.1007/978-94-007-5590-1-9
35. Hogan N. M., Joyce M. R., Kerin M. J., MicroRNA expression in colorectal cancer. Cancer Biomark 2012 11 6 239 243
36. Tokarz P., Blasiak J., The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Acta Biochimica Polonica 2012 59 4 467 474
37. Link A., Kupcinskas J., Wex T., Malfertheiner P., Macro-role of microRNA in gastric cancer. Digital Distribution 2012 30 3 255 267 10.1159/000336919
38. Wu W. K., Lee C. W., Cho C. H., Fan D., Wu K., Yu J., Sung J. J. Y., MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 2010 29 43 5761 5771 2-s2.0-78049346482 10.1038/onc.2010.352
39. Boeri M., Pastorino U., Sozzi G., Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis. Journal of Cancer 2012 18 3 268 274 10.1097/PPO.0b013e318258b743
40. Sand M., Sand D., Altmeyer P., Bechara F. G., MicroRNA in non-melanoma skin cancer. Cancer Biomark 2012 11 6 253 257
41. Hasuwa H., Ueda J., Ikawa M., Okabe M., miR-200b and miR-429 function in mouse ovulation and are essential for female fertility. Science 2013 341 6141 71 73
42. Yan B., Zhao L. H., Guo J. T., Zhao J. L., miR-429 regulation of osmotic stress transcription factor 1 (OSTF1) in tilapia during osmotic stress. Biochemical and Biophysical Research Communications 2012 426 3 294 298 10.1016/j.bbrc.2012.08.029
43. Hanahan D., Weinberg R. A., Hallmarks of cancer: the next generation. Cell 2011 144 5 646 674 2-s2.0-79952284127 10.1016/j.cell.2011.02.013
44. Pang R. W., Joh J. W., Johnson P. J., Monden M., Pawlik T. M., Poon R. T. P., Biology of hepatocellular carcinoma. Annals of Surgical Oncology 2008 15 4 962 971 2-s2.0-40549100994 10.1245/s10434-007-9730-z
45. Long X. D., Ma Y., Wei Y. P., Deng Z. L., The polymorphisms of GSTM1, GSTT1, HYL1 2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatology Research 2006 36 1 48 55 2-s2.0-33748604578 10.1016/j.hepres.2006.06.004 (Pubitemid 44375516)